The CEO also serves as CFO, which can be efficient in a very small organization but concentrates risk and may limit commercial execution bandwidth. The team advanced the Australian trial and trimmed expenses year over year, yet credibility will ultimately hinge on delivering clinically meaningful data and obtaining PMA approval.
Headcount is nine employees, leveraging consultants to conserve cash, which is appropriate for stage but heightens key‑person risk.







